p.90 抽出テキスト
636. Chu VH, Miro JM, Hoen B, Cabell CH, Pappas PA, Jones P, et al. Coagulase-negative staphylococcal prosthetic valve endocarditis–a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study. Heart 2009; 95:570–576. https://doi.org/10.1136/hrt.2008.152975 637. Jensen AD, Ostergaard L, Petersen JK, Graversen PL, Butt JH, Hadji-Turdeghal K, et al. Temporal trends of mortality in patients with infective endocarditis: a nationwide study. Eur Heart J Qual Care Clin Outcomes 2022;9:24–33. https://doi.org/10.1093/ ehjqcco/qcac011 638. Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Pressman GS, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One 2013;8:e82665. https://doi.org/10.1371/journal.pone.0082665 639. Oliver L, Lavoute C, Giorgi R, Salaun E, Hubert S, Casalta JP, et al. Infective endocarditis in octogenarians. Heart 2017;103:1602–1609. https://doi.org/10.1136/heartjnl-2016- 310853 640. Pazdernik M, Iung B, Mutlu B, Alla F, Riezebos R, Kong W, et al. Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry. Infection 2022;50:1191–1202. https://doi.org/10.1007/ s15010-022-01792-0 641. Ragnarsson S, Salto-Alejandre S, Strom A, Olaison L, Rasmussen M. Surgery is underused in elderly patients with left-sided infective endocarditis: a nationwide registry study. J Am Heart Assoc 2021;10:e020221. https://doi.org/10.1161/JAHA.120.020221 642. Ghanta RK, Pettersson GB. Surgical treatment of infective endocarditis in elderly patients: the importance of shared decision making. J Am Heart Assoc 2021;10:e022186. https://doi.org/10.1161/JAHA.121.022186 643. Lopez J, Revilla A, Vilacosta I, Sevilla T, Villacorta E, Sarria C, et al. Age-dependent profile of left-sided infective endocarditis: a 3-center experience. Circulation 2010;121: 892–897. https://doi.org/10.1161/CIRCULATIONAHA.109.877365 644. Stortecky S, Heg D, Tueller D, Pilgrim T, Muller O, Noble S, et al. Infective endocarditis after transcatheter aortic valve replacement. J Am Coll Cardiol 2020;75:3020–3030. https://doi.org/10.1016/j.jacc.2020.04.044 645. Regueiro A, Linke A, Latib A, Ihlemann N, Urena M, Walther T, et al. Association between transcatheter aortic valve replacement and subsequent infective endocarditis and in-hospital death. JAMA 2016;316:1083–1092. https://doi.org/10.1001/jama. 2016.12347 646. Kolte D, Goldsweig A, Kennedy KF, Abbott JD, Gordon PC, Sellke FW, et al. Comparison of incidence, predictors, and outcomes of early infective endocarditis after transcatheter aortic valve implantation versus surgical aortic valve replacement in the United States. Am J Cardiol 2018;122:2112–2119. https://doi.org/10.1016/j. amjcard.2018.08.054 647. Fauchier L, Bisson A, Herbert J, Lacour T, Bourguignon T, Etienne CS, et al. Incidence and outcomes of infective endocarditis after transcatheter aortic valve implantation versus surgical aortic valve replacement. Clin Microbiol Infect 2020;26:1368–1374. https://doi.org/10.1016/j.cmi.2020.01.036 648. Butt JH, Ihlemann N, De Backer O, Sondergaard L, Havers-Borgersen E, Gislason GH, et al. Long-term risk of infective endocarditis after transcatheter aortic valve replacement. J Am Coll Cardiol 2019;73:1646–1655. https://doi.org/10.1016/j.jacc.2018.12.078 649. Cahill TJ, Raby J, Jewell PD, Brennan PF, Banning AP, Byrne J, et al. Risk of infective endocarditis after surgical and transcatheter aortic valve replacement. Heart 2022; 108:639–647. https://doi.org/10.1136/heartjnl-2021-320080 650. Del Val D, Abdel-Wahab M, Linke A, Durand E, Ihlemann N, Urena M, et al. Temporal trends, characteristics, and outcomes of infective endocarditis after transcatheter aortic valve replacement. Clin Infect Dis 2021;73:e3750–e3758. https://doi.org/10.1093/ cid/ciaa1941 651. Bjursten H, Rasmussen M, Nozohoor S, Gotberg M, Olaison L, Ruck A, et al. Infective endocarditis after transcatheter aortic valve implantation: a nationwide study. Eur Heart J 2019;40:3263–3269. https://doi.org/10.1093/eurheartj/ehz588 652. Mentias A, Girotra S, Desai MY, Horwitz PA, Rossen JD, Saad M, et al. Incidence, predictors, and outcomes of endocarditis after transcatheter aortic valve replacement in the United States. JACC Cardiovasc Interv 2020;13:1973–1982. https://doi.org/10.1016/ j.jcin.2020.05.012 653. Regueiro A, Linke A, Latib A, Ihlemann N, Urena M, Walther T, et al. Infective endocarditis following transcatheter aortic valve replacement: comparison of balloon- versus self-expandable valves. Circ Cardiovasc Interv 2019;12:e007938. https://doi.org/10. 1161/CIRCINTERVENTIONS.119.007938 654. Salaun E, Sportouch L, Barral PA, Hubert S, Lavoute C, Casalta AC, et al. Diagnosis of infective endocarditis after TAVR: value of a multimodality imaging approach. JACC Cardiovasc Imaging 2018;11:143–146. https://doi.org/10.1016/j.jcmg.2017.05.016 655. Wahadat AR, Tanis W, Swart LE, Scholtens A, Krestin GP, van Mieghem N, et al. Added value of (18)F-FDG-PET/CT and cardiac CTA in suspected transcatheter aortic valve endocarditis. J Nucl Cardiol 2021;28:2072–2082. https://doi.org/10.1007/s12350- 019-01963-x 656. Mangner N, Leontyev S, Woitek FJ, Kiefer P, Haussig S, Binner C, et al. Cardiac surgery compared with antibiotics only in patients developing infective endocarditis after transcatheter aortic valve replacement. J Am Heart Assoc 2018;7:e010027. https:// doi.org/10.1161/JAHA.118.010027 657. Del Val D, Trottier M, Alperi A, Muntane-Carol G, Faroux L, Delarochelliere R, et al. (18)F-fluorodeoxyglucose uptake pattern in noninfected transcatheter aortic valves. Circ Cardiovasc Imaging 2020;13:e011749. https://doi.org/10.1161/CIRCIMAGING. 120.011749 658. Mangner N, del Val D, Abdel-Wahab M, Crusius L, Durand E, Ihlemann N. Surgical treatment of patients with infective endocarditis after transcatheter aortic valve implantation. J Am Coll Cardiol 2022;79:772–785. https://doi.org/10.1016/j.jacc.2021.11. 056 659. Santos-Martinez S, Alkhodair A, Nombela-Franco L, Saia F, Munoz-Garcia AJ, Gutierrez E, et al. Transcatheter aortic valve replacement for residual lesion of the aortic valve following “healed” infective endocarditis. JACC Cardiovasc Interv 2020;13: 1983–1996. https://doi.org/10.1016/j.jcin.2020.05.033 660. Bos D, De Wolf D, Cools B, Eyskens B, Hubrechts J, Boshoff D, et al. Infective endocarditis in patients after percutaneous pulmonary valve implantation with the stentmounted bovine jugular vein valve: clinical experience and evaluation of the modified Duke criteria. Int J Cardiol 2021;323:40–46. https://doi.org/10.1016/j.ijcard.2020.08. 058 661. Georgiev S, Ewert P, Eicken A, Hager A, Horer J, Cleuziou J, et al. Munich comparative study: prospective long-term outcome of the transcatheter melody valve versus surgical pulmonary bioprosthesis with up to 12 years of follow-up. Circ Cardiovasc Interv 2020;13:e008963. https://doi.org/10.1161/CIRCINTERVENTIONS.119.008963 662. Groning M, Tahri NB, Sondergaard L, Helvind M, Ersboll MK, Orbaek Andersen H. Infective endocarditis in right ventricular outflow tract conduits: a register-based comparison of homografts, contegra grafts and melody transcatheter valves. Eur J Cardiothorac Surg 2019;56:87–93. https://doi.org/10.1093/ejcts/ezy478 663. Lluri G, Levi DS, Miller E, Hageman A, Sinha S, Sadeghi S, et al. Incidence and outcome of infective endocarditis following percutaneous versus surgical pulmonary valve replacement. Catheter Cardiovasc Interv 2018;91:277–284. https://doi.org/10.1002/ccd. 27312 664. Malekzadeh-Milani S, Houeijeh A, Jalal Z, Hascoet S, Bakloul M, Aldebert P, et al. French national survey on infective endocarditis and the melody valve in percutaneous pulmonary valve implantation. Arch Cardiovasc Dis 2018;111:497–506. https://doi.org/ 10.1016/j.acvd.2017.10.007 665. McElhinney DB, Zhang Y, Aboulhosn JA, Morray BH, Biernacka EK, Qureshi AM, et al. Multicenter study of endocarditis after transcatheter pulmonary valve replacement. J Am Coll Cardiol 2021;78:575–589. https://doi.org/10.1016/j.jacc.2021.05.044 666. Nordmeyer J, Ewert P, Gewillig M, AlJufan M, Carminati M, Kretschmar O, et al. Acute and midterm outcomes of the post-approval MELODY registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur Heart J 2019;40:2255–2264. https://doi.org/10.1093/eurheartj/ehz201 667. O’Donnell C, Holloway R, Tilton E, Stirling J, Finucane K, Wilson N. Infective endocarditis following melody valve implantation: comparison with a surgical cohort. Cardiol Young 2017;27:294–301. https://doi.org/10.1017/S1047951116000494 668. Van Dijck I, Budts W, Cools B, Eyskens B, Boshoff DE, Heying R, et al. Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart 2015;101:788–793. https://doi.org/10.1136/heartjnl-2014-306761 669. Stammnitz C, Huscher D, Bauer UMM, Urban A, Nordmeyer J, Schubert S, et al. Nationwide registry-based analysis of infective endocarditis risk after pulmonary valve replacement. J Am Heart Assoc 2022;11:e022231. https://doi.org/10.1161/JAHA.121. 022231 670. Cheung G, Vejlstrup N, Ihlemann N, Arnous S, Franzen O, Bundgaard H, et al. Infective endocarditis following percutaneous pulmonary valve replacement: diagnostic challenges and application of intra-cardiac echocardiography. Int J Cardiol 2013;169: 425–429. https://doi.org/10.1016/j.ijcard.2013.10.016 671. Olsen T, Jorgensen OD, Nielsen JC, Thogersen AM, Philbert BT, Johansen JB. Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982–2018). Eur Heart J 2019;40:1862–1869. https://doi.org/10.1093/ eurheartj/ehz316 672. Da Costa A, Lelievre H, Kirkorian G, Celard M, Chevalier P, Vandenesch F, et al. Role of the preaxillary flora in pacemaker infections: a prospective study. Circulation 1998;97: 1791–1795. https://doi.org/10.1161/01.CIR.97.18.1791 673. Chamis AL, Peterson GE, Cabell CH, Corey GR, Sorrentino RA, Greenfield RA, et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001;104:1029–1033. https://doi.org/10. 1161/hc3401.095097 674. Madhavan M, Sohail MR, Friedman PA, Hayes DL, Steckelberg JM, Wilson WR, et al. Outcomes in patients with cardiovascular implantable electronic devices and bacteremia caused by Gram-positive cocci other than Staphylococcus aureus. Circ Arrhythm Electrophysiol 2010;3:639–645. https://doi.org/10.1161/CIRCEP.110.957514 675. Sohail MR, Palraj BR, Khalid S, Uslan DZ, Al-Saffar F, Friedman PA, et al. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB). Circ Arrhythm Electrophysiol 2015;8:137–144. https://doi.org/10. 1161/CIRCEP.114.002199 676. Uslan DZ, Dowsley TF, Sohail MR, Hayes DL, Friedman PA, Wilson WR, et al. Cardiovascular implantable electronic device infection in patients with ESC Guidelines 4037 Downloaded from academic.oup.com/eurheartj/article/44/39/3948/7243107 by guest on 07 October 2026